We develop first-in-class RNA-based therapies, with lead programs in Head & Neck Squamous Cell Carcinoma (HNSCC) and Facioscalpulohumeral Muscular Dystrophy (FSHD).
Our approach to drug design revolves around using genomic patient data to create highly tailored therapeutics – the right drug for the right patient.
Our proprietary DREAmiR™ platform utilizes genomic and outcome data from thousands of patients to identify underlying genetic changes that cause their disease, and then creates a novel RNA therapeutic that can directly target and fix that genetic abnormality.
Company Details
- Employees
- 13
- Founded
- -
- Address
- 704 Quince Orchard Road, Gaithersburg,m.d 20878,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- mirecule.com
- HQ
- Gaithersburg, M.D
Mirecule, Inc. Questions
Mirecule, Inc.'s website is mirecule.com
Mirecule, Inc.'s LinkedIn profile is https://www.linkedin.com/company/mirecule
Mirecule, Inc. has
13 employees.
View email and phone details for 13
employees at Mirecule, Inc..
Mirecule, Inc.'s industry is
Biotechnology Research
Mirecule, Inc.'s top competitors are
Gbi Bio,
Deka Biosciences, Inc,
Cartesian Therapeutics,
Genalyte, Inc.,
Frontier Bio,
Altimmune, Inc.,
Biohealth Innovation, Inc.,
Mimetas,
Gbi Biomanufacturing,
Macrogenics, Inc..
Mirecule, Inc.'s categories are Biotechnology Research
Mirecule, Inc.'s founding year is 2016
